Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 13 (5), 509-17

TARDBP Mutations in Frontotemporal Lobar Degeneration: Frequency, Clinical Features, and Disease Course

Affiliations

TARDBP Mutations in Frontotemporal Lobar Degeneration: Frequency, Clinical Features, and Disease Course

B Borroni et al. Rejuvenation Res.

Abstract

The 43-kD transactive response (TAR)-DNA-binding protein (TARDBP) mutations have been demonstrated to be causative of sporadic and familial forms of amyotrophic lateral sclerosis. More recently, these mutations have been reported in cases of frontotemporal lobar degeneration (FTLD). The aim of this study was to evaluate the role of TARDBP genetic variations in a large sample of consecutive patients with FTLD. A total of 252 FTLD patients were investigated. Each subject had a clinical and neuropsychological evaluation and a brain imaging study. The clinical diagnosis was confirmed by at least 1 year of follow up. The entire TARDBP gene, the intronic flaking regions, and the 5'-untranslated region (5'-UTR) were screened. Six genetic variations were identified in patients with behavioral variant frontotemporal dementia (FTD) and FTD with motor neuron disease phenotypes. Two of these mutations, namely N267S and M359V, lead to amino acid changes within exon 6. We further identified three genetic variations, i.e., Y214Y, IVS-IV + 45C/T, and 5'-UTR G/A, that could potentially affect the normal splicing process as predicted by in silico analyses. None of these genetic variations was found in healthy age-matched controls. Moreover, we identified a previously described benign variant, A66A, in 5 patients. Our study has confirmed and extended the list of pathogenetic mutations in the TARDBP gene in both apparently sporadic and familial FTLD patients. This work further supports the need for TARDBP screening in FTLD. Also intronic splicing that affects mutations should be considered as well.

Similar articles

See all similar articles

Cited by 29 PubMed Central articles

  • Motor Neuron Susceptibility in ALS/FTD
    AMG Ragagnin et al. Front Neurosci 13, 532. PMID 31316328. - Review
    Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the death of both upper and lower motor neurons (MNs) in the brain, brainstem and spin …
  • Autophagy as a Common Pathway in Amyotrophic Lateral Sclerosis
    DKH Nguyen et al. Neurosci Lett 697, 34-48. PMID 29626651. - Review
    Age-dependent neurodegenerative diseases are associated with a decline in protein quality control systems including autophagy. Amyotrophic lateral sclerosis (ALS) is a mo …
  • Frontotemporal Dementia: Latest Evidence and Clinical Implications
    JJ Young et al. Ther Adv Psychopharmacol 8 (1), 33-48. PMID 29344342. - Review
    FTD is an underdiagnosed group of neurological syndromes comprising multiple variants with distinct neurobiological profiles and presentations. Recent advances suggest th …
  • Neuropathology of Frontotemporal Lobar Degeneration: A Review
    VS Bahia et al. Dement Neuropsychol 7 (1), 19-26. PMID 29213815. - Review
    Frontotemporal lobar degeneration (FTLD) is the second most common cause of presenile dementia. Three main clinical variants are widely recognized within the FTLD spectru …
  • TDP-43 in the Spectrum of MND-FTLD Pathologies
    L Heyburn et al. Mol Cell Neurosci 83, 46-54. PMID 28687523. - Review
    The relationship between RNA-binding proteins, particularly TAR DNA binding protein 43 (TDP-43), and neurodegeneration is an important area of research. TDP-43 is involve …
See all "Cited by" articles

Publication types

Substances

LinkOut - more resources

Feedback